跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
FRUZAQLA fruquintinib 5 mg hard capsule bottle
Approved
STANDARD
FRUZAQLA fruquintinib 5 mg hard capsule bottle
Takeda Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
eda4dc9c84da9abd
Company
Takeda Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
eda4dc9c84da9abd
Product Name
FRUZAQLA fruquintinib 5 mg hard capsule bottle
Artg Id
422038
Artg Name
FRUZAQLA fruquintinib 5 mg hard capsule bottle
Sponsor
Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date
2024-10-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/fc37bdb45732fa3f9dd73d7fafa6b650.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/edc73d467bab6fd524c2915887bd9ff2.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
eda4dc9c84da9abd
Type
Standard
Back to TGA Approvals
FRUZAQLA fruquintinib 5 mg hard capsule bottle - TGA Drug Approval Details